Xiaodong Xu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 4
- Oncology top 10%
-
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 4
- Circular RNAs in diseases 4
-
- Ferroptosis and cancer prognosis 4
- Gastric Cancer Management and Outcomes 3
-
- Liver physiology and pathology 3
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Circulation (1 paper)The FASEB Journal (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaodong Xu
55 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 260
- Immunology 214
- Oncology 273
- Molecular Biology 645
- Pharmacology 42
Countries citing papers authored by Xiaodong Xu
This map shows the geographic impact of Xiaodong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Xu more than expected).
Fields of papers citing papers by Xiaodong Xu
This network shows the impact of papers produced by Xiaodong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Xu. The network helps show where Xiaodong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaodong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 14 | |
| 5 | 2022 | 19 | |
| 6 | 2022 | 34 | |
| 7 | 2022 | 25 | |
| 8 | 2021 | 28 | |
| 9 | 2021 | 55 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 44 | |
| 12 | 2019 | 129 | |
| 13 | 2019 | 17 | |
| 14 | 2018 | 21 | |
| 15 | 2017 | 0 | |
| 16 | 2017 | 3 | |
| 17 | 2015 | 1 | |
| 18 | 2015 | 23 | |
| 19 | [The application of uncut Roux-en-Y esophagojejunostomy with distal jejunal pouch on behalf of the stomach surgery in the digestive tract reconstruction after total gastrectomy]. | 2012 | 4 |
| 20 | 2012 | 33 |
About Xiaodong Xu
Xiaodong Xu is a scholar working on Cancer Research, Hematology and Molecular Biology, having authored 59 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (4 papers), Ferroptosis and cancer prognosis (4 papers), Epigenetics and DNA Methylation (4 papers), Circular RNAs in diseases (4 papers), Liver physiology and pathology (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Cancer Research (260 citations), Immunology (214 citations) and Oncology (273 citations). Xiaodong Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Guoping Ding, Liping Cao, Shengnan Jia, Yan Chen, Tao Shen, Ningning Liang, Huiyong Yin, Luxiao Li, Zai‐yuan Ye and Youcheng Zhang. Their work appears in journals such as Circulation, The FASEB Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.